SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses

Authors: Yuanmei Zhu, Danwei Yu, Yue Hu, Tong Wu, Huihui Chong, Yuxian He

Published: 2021-08-13

DOI: 10.1038/s41392-021-00698-x

Source: Full article

Abstract

No abstract found.